The increased rate of antimicrobial resistance in Acinetobacter baumannii made it
necessary to reconsider old antibiotics such as polymyxins and develop new drugs such as …

Objective: This study investigated the minimum inhibitory concentration (MIC) values and in
vitro activity of colistin in combination with tigecycline against carbapenem-resistant …

Purpose Colistin is a drug of last resort for treating multidrug-resistant Acinetobacter
baumannii infections. Unfortunately, colistin-resistant A. baumannii (CoR-AB) has been …

Objectives To describe colistin-resistant Acinetobacter baumannii isolates in Cape Town,
South Africa. Methods A. baumannii isolates identified on Vitek 2 Advanced Expert System …

Aim: The aim of this study was to investigate the prevalence and the mechanisms of
carbapenem and colistin resistance in Acinetobacter baumannii clinical isolates in an …

Background Acinetobacter baumannii has emerged as a major cause of nosocomial
outbreaks. It is particularly associated with nosocomial pneumonia and bloodstream …

Aims: Acinetobacter species usually affect hospitalized patients and are involved in many
infections associated with a high mortality rate. Management of infections caused by these …

The incidence of multidrug-resistant Acinetobacter baumannii (MDR A. baumannii) is
increasing worldwide and is leading to therapeutic problems. We investigated the in vitro …

Please cite this article as: Goudarzi H, Douraghi M, Ghalavand Z, Goudarzi M. Assessment
of antibiotic resistance pattern in Acinetobacter baumannii carrying bla oxA type genes …

Introduction: Acinetobacter baumannii is an important cause of nosocomial infections
worldwide. It is difficult to control, and the infections caused by it are difficult to treat, because …